VanEck Biotech ETF BBH | NASDAQ
BBH last paid $0.9565 a share on Dec 24, 2025, and returned 27.0% over 12 months with distributions counted. · 1-year total return +27.0% · Track BBH in a free portfolio
Company Overview:
10 Year BBH Performance Metrics:
BBH Dividend Payments & Yield
BBH Dividends Info:
Projected Future Returns & Dividends for BBH
Based on past 10-year performance, here are BBH growth metrics:
Share price CAGR of +7.84%
Dividend CAGR of +6.31%
Using BBH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| BBH (DRIP) | BBH - No DRIP | |
|---|---|---|
| Current Price | $239.49 | $239.49 |
| Start Shares | 41.76 | 41.76 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 43.35 | 41.76 |
| Dividends Payment | $1.76 | $1.76 |
| Annual Dividends | $76 | $74 |
| Yield on cost | 0.76% | 0.74% |
| Share Price | $509.60 | $509.60 |
| Total Dividends | $545 | $534 |
| Final Value | $22,090 | $21,813 |
NOTE: Above numbers are our estimate based on BBH's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Company Info
VanEck Biotech ETF (BBH) had its IPO on 1999-11-23, and is traded on NASDAQ stock exchange.
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
BBH website: https://www.vaneck.com/us/en/investments/biotech-etf-bbh/
DCF model unavailable for BBH — no fundamentals on file (ETFs and funds are not modelable).
